Hart, Robert G.

Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation

Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 4,793

Apixaban in patients with atrial fibrillation

Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine

Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management

Cited by 2,483

Rivaroxaban with or without aspirin in stable cardiovascular disease

Eikelboom, J. W., Connolly, S. J., Bosch, J., Dagenais, G. R., Hart, R. G., Shestakovska, O., Diaz, R., Alings, M., Lonn, E. M., Anand, S. S., et al. (2017) · New England Journal of Medicine

Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

Cited by 2,438

Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke

Acute Ischemic Stroke ManagementCardiovascular Health and Risk Factors

Cited by 1,306

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Anand, S. S., Bosch, J., Eikelboom, J. W., Connolly, S. J., Diaz, R., Widimsky, P., Aboyans, V., Alings, M., Kakkar, A. K., Keltai, K., et al. (2018) · The Lancet

Antiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease Management

Cited by 879

Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin

Gage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 749

Atrial Fibrillation and Stroke: Concepts and Controversies

Hart, R. G., & Halperin, J. L. (2001) · Stroke

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 318

Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES

Vanassche, T., Lauw, M. N., Eikelboom, J. W., Healey, J. S., Hart, R. G., Alings, M., Avezum, A., Diaz, R., Hohnloser, S. H., Lewis, B. S., et al. (2015) · European Heart Journal

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 313

Atrial fibrillation and stroke: new ideas, persisting dilemmas

Halperin, J. L., & Hart, R. G. (1988) · Stroke

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 231

A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin

van Walraven, C., Hart, R. G., Wells, G. A., Petersen, P., Koudstaal, P. J., Gullov, A. L., Hellemons, B. S. P., Koefed, B. G., & Laupacis, A. (2003) · Archives of Internal Medicine

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 209

Warfarin in atrial fibrillation patients with moderate chronic kidney disease

Hart, R. G., Pearce, L. A., Asinger, R. W., & Herzog, C. A. (2011) · Clinical Journal of the American Society of Nephrology

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 204

Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial

Diener, H.-C., Eikelboom, J., Connolly, S. J., Joyner, C. D., Hart, R. G., Lip, G. Y., O'Donnell, M., Hohnloser, S. H., Hankey, G. J., Shestakovska, O., et al. (2012) · The Lancet Neurology

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 177

Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation

Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 173

The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial

Gerstein, H. C., Hart, R., Colhoun, H. M., Diaz, R., Lakshmanan, M., Botros, F. T., Probstfield, J., Riddle, M. C., Rydén, L., Atisso, C. M., et al. (2020) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementAcute Ischemic Stroke Management

Cited by 137

Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial

Pearce, L. A., McClure, L. A., Anderson, D. C., Jacova, C., Sharma, M., Hart, R. G., & Benavente, O. R. (2014) · The Lancet Neurology

Dementia and Cognitive Impairment ResearchBlood Pressure and Hypertension Studies

Cited by 135

Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin: The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial

Flaker, G. C., Eikelboom, J. W., Shestakovska, O., Connolly, S. J., Kaatz, S., Budaj, A., Husted, S., Yusuf, S., Lip, G. Y. H., & Hart, R. G. (2012) · Stroke

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 94

Effect of Addition of Clopidogrel to Aspirin on Mortality: Systematic Review of Randomized Trials

Palacio, S., Hart, R. G., Pearce, L. A., & Benavente, O. R. (2012) · Stroke

Antiplatelet Therapy and Cardiovascular DiseasesAcute Ischemic Stroke Management

Cited by 47